MarketCap
Facebook
X
TelegramAkers Biosciences, Inc. General and Administrative Expenses 2011-2025 | AKER
General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.What these expenses include
- Salaries of administrative staff (executives, HR, accountants, legal personnel)
- Office rent and utilities
- Office equipment and IT infrastructure
- Professional services (auditors, lawyers, consultants)
- Insurance
- General administrative travel and representation expenses
- Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure - Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit - Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry - Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines
Annual General and Administrative Expenses Akers Biosciences, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| - | 3.73 M | 5.67 M | 4.08 M | 3.01 M | 4.03 M | 3.98 M | 1.52 M | 1.49 M | 3.28 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.67 M | 1.49 M | 3.42 M |
General and Administrative Expenses of other stocks in the Medical instruments industry
| Issuer | General and Administrative Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Baxter International
BAX
|
2.97 B | $ 19.26 | -0.64 % | $ 9.82 B |  USA |
 |
Becton, Dickinson and Company
BDX
|
5.28 B | $ 195.4 | -0.46 % | $ 56.2 B | USA |
 |
Luminex Corporation
LMNX
|
140 M | - | - | $ 1.75 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
8.79 M | $ 5.5 | -1.08 % | $ 111 M | USA |
 |
Antares Pharma, Inc.
ATRS
|
62.8 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
198 M | - | -1.18 % | $ 3.4 B | USA |
 |
Harvard Bioscience
HBIO
|
22.8 M | $ 0.67 | -4.17 % | $ 28.4 M | USA |
 |
CRH Medical Corporation
CRHM
|
8.44 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
941 M | - | -0.05 % | $ 10.3 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
671 M | - | -0.02 % | $ 16.3 B | USA |
 |
Repro Med Systems
KRMD
|
20.4 M | $ 6.09 | -2.33 % | $ 278 M | USA |
 |
Alcon
ALC
|
251 M | $ 80.33 | -0.03 % | $ 40.4 B |  Schweiz |
 |
LeMaitre Vascular
LMAT
|
36.3 M | $ 82.65 | -1.35 % | $ 1.86 B | USA |
 |
iRhythm Technologies
IRTC
|
419 M | $ 177.22 | 0.35 % | $ 5.53 B | USA |
 |
ICU Medical
ICUI
|
639 M | $ 147.18 | -0.47 % | $ 3.59 B | USA |
 |
Masimo Corporation
MASI
|
744 M | $ 131.07 | -1.28 % | $ 6.99 B | USA |
 |
AtriCure
ATRC
|
291 M | $ 40.27 | -0.15 % | $ 1.89 B | USA |
 |
Atrion Corporation
ATRI
|
23.2 K | - | - | $ 810 M | USA |
 |
electroCore
ECOR
|
27.2 M | $ 4.86 | -1.92 % | $ 26.8 K | USA |
 |
Merit Medical Systems
MMSI
|
400 M | $ 88.52 | 1.29 % | $ 5.15 B | USA |
 |
Isoray
ISR
|
26.6 M | - | 0.03 % | $ 108 M | USA |
 |
AngioDynamics
ANGO
|
42.1 M | $ 12.88 | -1.68 % | $ 526 M | USA |
 |
The Cooper Companies
COO
|
1.63 B | $ 82.23 | -0.48 % | $ 16.4 B | USA |
 |
Glaukos Corporation
GKOS
|
224 M | $ 115.3 | -1.01 % | $ 5.58 B | USA |
 |
Haemonetics Corporation
HAE
|
437 M | $ 80.86 | 0.7 % | $ 4.07 B | USA |
 |
InfuSystem Holdings
INFU
|
46.1 M | $ 8.94 | -0.26 % | $ 185 M | USA |
 |
OraSure Technologies
OSUR
|
46.2 M | $ 2.44 | 0.62 % | $ 182 M | USA |
 |
Intuitive Surgical
ISRG
|
2.14 B | $ 575.19 | -0.45 % | $ 204 B | USA |
 |
ResMed
RMD
|
739 M | $ 242.92 | -0.8 % | $ 35.5 B | USA |
 |
Microbot Medical
MBOT
|
4.13 M | $ 2.11 | -2.09 % | $ 21.5 M |  Israel |
 |
Milestone Scientific
MLSS
|
12.3 M | $ 0.29 | 0.7 % | $ 23.1 M | USA |
 |
Nephros
NEPH
|
8.91 M | $ 4.9 | -0.61 % | $ 50.9 M | USA |
 |
STERIS plc
STE
|
1.33 B | $ 256.7 | 0.57 % | $ 25.3 B | USA |
 |
NeuroMetrix
NURO
|
6.33 M | - | 5.05 % | $ 9.02 M | USA |
 |
Envista Holdings Corporation
NVST
|
1.16 B | $ 21.9 | -0.43 % | $ 3.77 B | USA |
 |
Predictive Oncology
POAI
|
7.42 M | - | - | $ 32.4 M | USA |
 |
Stereotaxis
STXS
|
14 M | $ 2.3 | -6.33 % | $ 186 M | USA |
 |
Pro-Dex
PDEX
|
4.84 M | $ 40.27 | 2.07 % | $ 132 M | USA |
 |
Pulse Biosciences
PLSE
|
15.8 M | $ 14.09 | -2.15 % | $ 677 M | USA |
 |
Utah Medical Products
UTMD
|
11 M | $ 57.51 | 1.34 % | $ 209 M | USA |
 |
Repligen Corporation
RGEN
|
219 M | $ 165.64 | -0.34 % | $ 9.23 M | USA |
 |
BioLife Solutions
BLFS
|
40.5 M | $ 25.07 | 0.68 % | $ 1.15 B | USA |
 |
Retractable Technologies
RVP
|
13.6 M | $ 0.8 | -3.84 % | $ 23.9 M | USA |
 |
STAAR Surgical Company
STAA
|
89.9 M | $ 23.33 | -0.09 % | $ 1.15 B | USA |
 |
Teleflex Incorporated
TFX
|
995 M | $ 122.83 | 0.03 % | $ 5.75 B | USA |
 |
West Pharmaceutical Services
WST
|
338 M | $ 275.92 | 0.48 % | $ 20.1 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
1.6 B | $ 11.32 | -1.74 % | $ 2.3 B | USA |